Show simple item record

dc.contributor.authorChege, Evelynn N
dc.date.accessioned2017-12-18T07:47:19Z
dc.date.available2017-12-18T07:47:19Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/11295/101987
dc.description.abstractCancer is a growing disease burden in our country.Contributing to it are central nervous tumours and most commonly glial tumours which are intracranial.knowing the type of tumour the patient suffers from dictates treatment options and the patient's pronosis.The most common malignant glial tumour is glial is glioblastoma which may be primary or IDHI mutatin glioblastoma (secondary.)
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectRole of Immunohistochemistryen_US
dc.titleRole of Immunohistochemistry in the Diagnosis of Glioblastoma and Anaplastic Astrocytoma at Kenyatta National Hospitalen_US
dc.typeThesisen_US
dc.description.departmenta Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine, Moi University, Eldoret, Kenya


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States